John H. Le

Array ( [id] => 20613594 [patent_doc_number] => 20260083679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-03-26 [patent_title] => ADAGRASIB SOLID PHARMACEUTICAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 19/407221 [patent_app_country] => US [patent_app_date] => 2025-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6708 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19407221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20692746 [patent_doc_number] => 20260124149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-05-07 [patent_title] => MODALITY, METHOD OF PRODUCING MODALITY, AND METHOD OF ADMINISTERING MODALITY INCLUDING POLYHYDRADED IONOGEN SOLUTION IN THE TREATMENT OF CHRONIC WOUNDS [patent_app_type] => utility [patent_app_number] => 19/380413 [patent_app_country] => US [patent_app_date] => 2025-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19380413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20541241 [patent_doc_number] => 20260048129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-19 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE [patent_app_type] => utility [patent_app_number] => 19/368973 [patent_app_country] => US [patent_app_date] => 2025-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19368973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20425293 [patent_doc_number] => 20250387380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-25 [patent_title] => AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 19/308925 [patent_app_country] => US [patent_app_date] => 2025-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29539 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19308925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20554205 [patent_doc_number] => 20260053985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-26 [patent_title] => ENHANCED BIRTH TISSUE ALLOGRAFTS AND METHODS OF MANUFACTURE [patent_app_type] => utility [patent_app_number] => 19/306874 [patent_app_country] => US [patent_app_date] => 2025-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6285 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19306874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20391738 [patent_doc_number] => 20250367213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-04 [patent_title] => IMMEDIATE RELEASE MULTILAYER TABLET [patent_app_type] => utility [patent_app_number] => 19/301647 [patent_app_country] => US [patent_app_date] => 2025-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9671 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19301647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20335418 [patent_doc_number] => 20250339538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-11-06 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE [patent_app_type] => utility [patent_app_number] => 19/270315 [patent_app_country] => US [patent_app_date] => 2025-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19270315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20277727 [patent_doc_number] => 20250302969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-02 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE [patent_app_type] => utility [patent_app_number] => 19/238194 [patent_app_country] => US [patent_app_date] => 2025-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19238194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20320020 [patent_doc_number] => 20250332108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-30 [patent_title] => COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL [patent_app_type] => utility [patent_app_number] => 19/221432 [patent_app_country] => US [patent_app_date] => 2025-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66725 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19221432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20178263 [patent_doc_number] => 20250262221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => IMMEDIATE RELEASE MULTILAYER TABLET [patent_app_type] => utility [patent_app_number] => 19/190529 [patent_app_country] => US [patent_app_date] => 2025-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19190529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20185855 [patent_doc_number] => 12396955 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-26 [patent_title] => Tamper resistant dosage forms [patent_app_type] => utility [patent_app_number] => 19/174583 [patent_app_country] => US [patent_app_date] => 2025-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 43 [patent_no_of_words] => 57361 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19174583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20231199 [patent_doc_number] => 20250288518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-18 [patent_title] => METHODS OF USING RADIPRODIL IN THE TREATMENT OF DISORDERS [patent_app_type] => utility [patent_app_number] => 19/171169 [patent_app_country] => US [patent_app_date] => 2025-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41900 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19171169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19830795 [patent_doc_number] => 20250082581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => TAMPER RESISTANT DOSAGE FORMS [patent_app_type] => utility [patent_app_number] => 18/953603 [patent_app_country] => US [patent_app_date] => 2024-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60830 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18953603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19752861 [patent_doc_number] => 20250041426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-06 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE [patent_app_type] => utility [patent_app_number] => 18/921291 [patent_app_country] => US [patent_app_date] => 2024-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3804 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18921291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19938870 [patent_doc_number] => 12310984 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-05-27 [patent_title] => Composition and method for reducing risk of hypocalcemia in periparturient ruminant animals [patent_app_type] => utility [patent_app_number] => 18/830440 [patent_app_country] => US [patent_app_date] => 2024-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 0 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18830440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19613135 [patent_doc_number] => 20240398815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => ADAGRASIB SOLID PHARMACEUTICAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/794390 [patent_app_country] => US [patent_app_date] => 2024-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18794390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19570233 [patent_doc_number] => 20240374525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => ADAGRASIB SOLID PHARMACEUTICAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/784276 [patent_app_country] => US [patent_app_date] => 2024-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10074 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18784276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19526503 [patent_doc_number] => 20240350405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => FAST DISINTEGRATING TABLET [patent_app_type] => utility [patent_app_number] => 18/760150 [patent_app_country] => US [patent_app_date] => 2024-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14061 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18760150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19430838 [patent_doc_number] => 20240299336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => SHELF-STABLE FORMULATIONS OF BENZOYL PEROXIDE AND METHODS OF PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 18/666141 [patent_app_country] => US [patent_app_date] => 2024-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25104 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18666141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19768340 [patent_doc_number] => 20250049766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => HIGH DOSAGE TEBIPENEM PIVOXIL TABLET FORMULATION [patent_app_type] => utility [patent_app_number] => 18/665330 [patent_app_country] => US [patent_app_date] => 2024-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18410 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18665330 [rel_patent_id] =>[rel_patent_doc_number] =>)